Nome |
# |
Post-testicular cystic disease in patients with autosomal dominant polycystic kidney disease (ADPKD): untrasound and seminal aspects, file dfe4d227-5dd4-bb0a-e053-d805fe0a78d9
|
202
|
Propyonil-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease (PAD) and end stage renal disease (ESRD), file dfe4d227-14dd-bb0a-e053-d805fe0a78d9
|
39
|
Renal haemodynamics and coronary atherosclerotic burden are associated in patients with hypertension and mild coronary artery disease, file dfe4d229-d355-bb0a-e053-d805fe0a78d9
|
30
|
Comparison of the CBA-H and SF-36 for the screening of the psychological and behavioural variables in chronic dialysis patients., file dfe4d227-dc34-bb0a-e053-d805fe0a78d9
|
19
|
Inflammation and Aortic Pulse Wave Velocity: A Multicenter Longitudinal Study in Patients With Inflammatory Bowel Disease, file dfe4d229-988f-bb0a-e053-d805fe0a78d9
|
18
|
Letter regarding the article "The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study"., file dfe4d229-d5b6-bb0a-e053-d805fe0a78d9
|
16
|
Exercise in patients on dialysis: A multicenter, randomized clinical trial, file dfe4d22d-80b7-bb0a-e053-d805fe0a78d9
|
16
|
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome, file dfe4d229-8752-bb0a-e053-d805fe0a78d9
|
15
|
Inflammation and aortic stiffness: An individual participant data meta-analysis in patients with inflammatory bowel disease, file dfe4d229-0a7a-bb0a-e053-d805fe0a78d9
|
14
|
Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensive patients, file dfe4d229-d579-bb0a-e053-d805fe0a78d9
|
14
|
A systematic review of arterial stiffness, wave reflection and air pollution, file dfe4d229-b0a2-bb0a-e053-d805fe0a78d9
|
13
|
Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention, file dfe4d227-34e9-bb0a-e053-d805fe0a78d9
|
11
|
The effect of increasing age
on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care., file dfe4d227-31b0-bb0a-e053-d805fe0a78d9
|
10
|
Triglycerides and aortic pulse wave velocity in patients with chronic inflammation, file dfe4d229-1637-bb0a-e053-d805fe0a78d9
|
9
|
Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: A secondary analysis of the EXCITE trial, file dfe4d229-d353-bb0a-e053-d805fe0a78d9
|
8
|
La PET con C-Metionina: un approccio propositivo nel trattamento dell'iperparatiroidismo, file dfe4d229-ec7a-bb0a-e053-d805fe0a78d9
|
8
|
Renal function and ultrasound imaging in elderly subjects, file dfe4d226-ff0f-bb0a-e053-d805fe0a78d9
|
7
|
Heart rate, age and the risk progression to kidney failure in patients with CKD, file dfe4d227-01e5-bb0a-e053-d805fe0a78d9
|
7
|
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial, file dfe4d22d-dbd5-bb0a-e053-d805fe0a78d9
|
7
|
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome, file dfe4d22e-8d6f-bb0a-e053-d805fe0a78d9
|
7
|
Renal transplantation parenchymal complications: what Doppler ultrasound can and cannot do, file df95259b-b9ba-4524-8daf-c47d5831f1d8
|
6
|
Renal transplant vascular complications: the role of Doppler ultrasound, file dfe4d227-2341-bb0a-e053-d805fe0a78d9
|
6
|
Fitness for entering a simple exercise program and mortality: a study corollary to the exercise introduction to enhance performance in dialysis (excite) trial, file dfe4d227-304c-bb0a-e053-d805fe0a78d9
|
6
|
Blood pressor determinants of ventricular hypertrophy in haemodialysis patients, file dfe4d227-425a-bb0a-e053-d805fe0a78d9
|
6
|
Physical performance and clinical outcomes in dialysis patients: a secondary analysis of the excite trial, file dfe4d227-3335-bb0a-e053-d805fe0a78d9
|
5
|
Resistive intrarenal index: myth or reality?, file dfe4d227-4b07-bb0a-e053-d805fe0a78d9
|
5
|
Comportamento delle transaminasi sieriche in corso di infezione da HBV e HCV in pazienti emodializzati, file dfe4d227-0679-bb0a-e053-d805fe0a78d9
|
4
|
HYPEROMOCISTEINEMIA PREDICTS CARDIOVASCULAR OUTCOMES IN HEMODIALYSIS PATIENTS, file dfe4d227-22f0-bb0a-e053-d805fe0a78d9
|
4
|
High Variability of Fabry Disease Manifestations in an Extended Italian Family, file dfe4d227-33bd-bb0a-e053-d805fe0a78d9
|
4
|
Prognosis of CKD patients receiving outpatient nephrology care in Italy, file dfe4d227-98a0-bb0a-e053-d805fe0a78d9
|
4
|
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression, file dfe4d229-e06e-bb0a-e053-d805fe0a78d9
|
4
|
Norepinephrine and concentric hypertrophy in patients with end-stage renal disease, file dfe4d226-f5e2-bb0a-e053-d805fe0a78d9
|
3
|
Screening of relatives of anti-hepatitis-C virus positive hemodialysed patients (preliminary data ), file dfe4d227-137f-bb0a-e053-d805fe0a78d9
|
3
|
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease, file dfe4d227-174a-bb0a-e053-d805fe0a78d9
|
3
|
IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients
in relation to dialytic age, file dfe4d227-1750-bb0a-e053-d805fe0a78d9
|
3
|
Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients, file dfe4d227-1f1a-bb0a-e053-d805fe0a78d9
|
3
|
Magnesium, calcium and potassium: "no one was born alone", file dfe4d227-24d9-bb0a-e053-d805fe0a78d9
|
3
|
Nutrition and heart function in capd patients, file dfe4d227-c82b-bb0a-e053-d805fe0a78d9
|
3
|
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients, file dfe4d229-0afa-bb0a-e053-d805fe0a78d9
|
3
|
Vascular dysfunction in Cardiorenal Syndrome type 4, file dfe4d22a-4417-bb0a-e053-d805fe0a78d9
|
3
|
FIBRINOGEN, MORTALITY AND INCIDENT CARDIOVASCULAR COMPLICATIONS IN END-STAGE RENAL FAILURE;, file dfe4d226-f48c-bb0a-e053-d805fe0a78d9
|
2
|
Utilità dell’sCD14-ST per la diagnosi di sepsi nel paziente con insufficienza renale [Usefulness of sCD14-ST in the diagnosis of sepsis in patient with renal failure], file dfe4d227-00d8-bb0a-e053-d805fe0a78d9
|
2
|
Malattia renale IgG-4 correlata: cosa il
nefrologo deve sapere [IgG4-related kidney disease: what the nephrologist needs to know], file dfe4d227-00ec-bb0a-e053-d805fe0a78d9
|
2
|
Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer ., file dfe4d227-067a-bb0a-e053-d805fe0a78d9
|
2
|
THE GLU298ASP VARIANT OF NITRIC OXIDE SYNTHASE INTERACTS WITH ASYMMETRIC DIMETHYL ARGININE IN DETERMINING CARDIOVASCULAR MORTALITY IN PATIENTS WITH END-STAGE RENAL DISEASE, file dfe4d227-081c-bb0a-e053-d805fe0a78d9
|
2
|
Parathyroid hormone in a population of elderly patients on hemodialysis (Preliminary data ), file dfe4d227-137d-bb0a-e053-d805fe0a78d9
|
2
|
Valutazione del rischio di infezione da virus dell'epatite delta (HDV)in una popolazione di emodializzati: significato della determinazione degli anticorpi sierici anti delta [Evaluation of the risk of hepatitis delta virus (HDV) infection in a population of hemodialyzed patients: significance of the determination of anti-delta antibodies in the blood], file dfe4d227-1381-bb0a-e053-d805fe0a78d9
|
2
|
ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVELS IN CHRONIC KIDNEY DISEASE: A SALTY QUESTION?, file dfe4d227-15fc-bb0a-e053-d805fe0a78d9
|
2
|
Molecular and clinical studies in five index cases with novel mutations in the GLA gene, file dfe4d227-1616-bb0a-e053-d805fe0a78d9
|
2
|
THE SELF-LOCATING CATHETER: CLINICAL EXPERIENCE AND FOLLOW-UP, file dfe4d227-200e-bb0a-e053-d805fe0a78d9
|
2
|
ITALIAN AUDIT ON THERAPY OF HYPERTENSION IN CHRONIC KIDNEY DISEASE: TABLE-CKD STUDY, file dfe4d227-409b-bb0a-e053-d805fe0a78d9
|
2
|
Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling, file dfe4d227-45b7-bb0a-e053-d805fe0a78d9
|
2
|
Renal artery diameter: a “new” parameter beyond an old disease - the renal artery stenosis, file dfe4d227-4e9f-bb0a-e053-d805fe0a78d9
|
2
|
Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients, file dfe4d227-8b12-bb0a-e053-d805fe0a78d9
|
2
|
Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease, file dfe4d227-97d9-bb0a-e053-d805fe0a78d9
|
2
|
PROGNOSTIC IMPACT OF THE IN DEXTATION OF LEFT VENTRICULAR MASS IN PATIENTS UNDERGOING DIALYSIS, file dfe4d227-9b6e-bb0a-e053-d805fe0a78d9
|
2
|
Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients, file dfe4d227-a0a4-bb0a-e053-d805fe0a78d9
|
2
|
Aberrant right subclavian artery laceration due to internal jugular vein catheterization treated by stent -graft implantation, file dfe4d227-a158-bb0a-e053-d805fe0a78d9
|
2
|
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease, file dfe4d227-a643-bb0a-e053-d805fe0a78d9
|
2
|
FIBRINOGEN, MORTALITY AND INCIDENT CARDIOVASCULAR COMPLICATIONS IN END-STAGE RENAL FAILURE;, file dfe4d227-b4fb-bb0a-e053-d805fe0a78d9
|
2
|
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease, file dfe4d227-d1ab-bb0a-e053-d805fe0a78d9
|
2
|
Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients, file dfe4d228-cbc6-bb0a-e053-d805fe0a78d9
|
2
|
The effect of tumor necrosis factor antagonists on functional aortic stiffening, file dfe4d228-debe-bb0a-e053-d805fe0a78d9
|
2
|
Expert opinion of nephrologists about the effectiveness of low-protein diet in different stages of chronic kidney disease (CKD)., file dfe4d229-d22c-bb0a-e053-d805fe0a78d9
|
2
|
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy, file dfe4d229-e0cb-bb0a-e053-d805fe0a78d9
|
2
|
LEFT VENTRICULAR HYPERTROPHY AND ASYMMETRIC DIMETHYLARGININR (ADMA) IN PATIENTS WITH ESRD, file dfe4d22d-b982-bb0a-e053-d805fe0a78d9
|
2
|
Gli inibitori del trasportatore Sodio-Glucosio di tipo 2 (SGLT2) nell’insufficienza renale cronica [Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors in CKD], file dfe4d22e-5144-bb0a-e053-d805fe0a78d9
|
2
|
Prevalence and prognosis of mild anemia in non-dialysis chronic kidney disease: A prospective cohort study in outpatient renal clinics, file 2aadc595-985a-4679-97b1-3f66cf02d137
|
1
|
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure, file dfe4d226-f564-bb0a-e053-d805fe0a78d9
|
1
|
Somatopsychic correlates and quality of life of the dialyzed patient: a cross-sectional study, file dfe4d227-052d-bb0a-e053-d805fe0a78d9
|
1
|
Comparative study of biochemical markers of bone formation in relation to different dialysis age, file dfe4d227-067b-bb0a-e053-d805fe0a78d9
|
1
|
Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients, file dfe4d227-1094-bb0a-e053-d805fe0a78d9
|
1
|
Le disfunzioni erettive nel paziente sottoposto a trapianto renale [Erectile disorders in patients receiving renal transplantation], file dfe4d227-137e-bb0a-e053-d805fe0a78d9
|
1
|
PLASMA NOREPINEPHRINE PREDICTIS SURVIVAL AND INCIDENT CARDIOVASCULAR EVENTS IN PATIENTIS WITH END- STAGE RENAL DISEASE, file dfe4d227-2176-bb0a-e053-d805fe0a78d9
|
1
|
CHLAMYDIA PNEUMONIAE, OVERALL AND CARDIOVASCULAR MORTALITY IN END STAGE RENAL DISEASE, file dfe4d227-2179-bb0a-e053-d805fe0a78d9
|
1
|
The MAURO Study :baseline characteristics and compliance with guidelines targets, file dfe4d227-26b0-bb0a-e053-d805fe0a78d9
|
1
|
Inflammatory status in patients with chronic renal failure: the role of PTX3 and pro inflammatory cytokines, file dfe4d227-27a3-bb0a-e053-d805fe0a78d9
|
1
|
Valutazione clinica dell'efficacia terapeutica dell'acebutololo nell'ipertensione arteriosa., file dfe4d227-2cc1-bb0a-e053-d805fe0a78d9
|
1
|
Il fumo, la pressione arteriosa e l'albuminemia sono fattori predittivi indipendenti dal danno vascolare negli uremici in dialisi, file dfe4d227-2cc2-bb0a-e053-d805fe0a78d9
|
1
|
Prevalenza degli anticorpi sierici anti-virus dell'epatite C in pazienti emodializzati., file dfe4d227-2cc3-bb0a-e053-d805fe0a78d9
|
1
|
DIAGNOSTIC POTENZIAL OF CARDIAC NATRIURETIC PEPTIDES IN DIALYSIS PATIENTS, file dfe4d227-2d38-bb0a-e053-d805fe0a78d9
|
1
|
SMOKING,BLOOD PRESSURE AND SERUM ALBUMIN ARE MAJOR DETERMINANTS OF CAROTID ATHEROSCLEROSIS IN DIALISIS PATIENTS., file dfe4d227-2d3a-bb0a-e053-d805fe0a78d9
|
1
|
Pazienti con insufficienza renale cronica:risultati dallo studio Nefrodata®, file dfe4d227-33b9-bb0a-e053-d805fe0a78d9
|
1
|
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis, file dfe4d227-3ac6-bb0a-e053-d805fe0a78d9
|
1
|
PLASMA CONCENTRATION OF ASYMMETRICAL DYMETHYLARGININE AND MORTALITY IN PATIENTS WITH END STAGE RENAL DISEASE: “A PROSPECTIVE STUDY” ., file dfe4d227-415d-bb0a-e053-d805fe0a78d9
|
1
|
Contrast-enhanced ultrasound (CEUS) in nephrology: Has the time come for its widespread use?, file dfe4d227-422d-bb0a-e053-d805fe0a78d9
|
1
|
Review: UPDATE sul metabolismo del magnesio, file dfe4d227-4456-bb0a-e053-d805fe0a78d9
|
1
|
IL2 and its receptors in elderly subjects on hemodialysis, file dfe4d227-8617-bb0a-e053-d805fe0a78d9
|
1
|
Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients, file dfe4d227-95e6-bb0a-e053-d805fe0a78d9
|
1
|
Prospective Study of Neuropeptide Y as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease, file dfe4d227-a9c2-bb0a-e053-d805fe0a78d9
|
1
|
Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: A prospective study, file dfe4d227-aeb2-bb0a-e053-d805fe0a78d9
|
1
|
LONG –TERM CAPD PATIENTS ARE VOLUME EXPANDED AND DISPLAY MORE SEVER LEFT VENTRICULAR HYPERTROPHY HEMODIALYSIS PATIENTS, file dfe4d227-af32-bb0a-e053-d805fe0a78d9
|
1
|
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure, file dfe4d227-b510-bb0a-e053-d805fe0a78d9
|
1
|
Il rituximab nella terapia delle glomerulonefriti primitive e secondarie [Use of rituximab in primary and secondary glomerulonephritis], file dfe4d228-d2fb-bb0a-e053-d805fe0a78d9
|
1
|
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease, file dfe4d229-09e1-bb0a-e053-d805fe0a78d9
|
1
|
Digoxin and Hypermagnesuria, file dfe4d229-d57b-bb0a-e053-d805fe0a78d9
|
1
|
Arteriovenous fistula and pre-surgery mapping: Potential role of physical exercise on endothelial function, file dfe4d229-d899-bb0a-e053-d805fe0a78d9
|
1
|
Renal diseases related to MYH9 disorders, file dfe4d229-e3eb-bb0a-e053-d805fe0a78d9
|
1
|
Peritonite da Candida e sepsi da Acinetobacter baumannii in dialisi peritoneale: una associazione con la prognosi non è sempre sfavorevole, file dfe4d229-e532-bb0a-e053-d805fe0a78d9
|
1
|
I microRNA nelle principali patologie renali: una nuova frontiera per il nefrologo [miRNAs in main renal diseases: a new frontier for the nephrologist], file dfe4d229-ee8a-bb0a-e053-d805fe0a78d9
|
1
|
Totale |
638 |